Award
National Cancer Institute 11194517
Pilot Project 2: Comprehensive characterization of Immune Features Linked to Genetic Variants and Response to Immunotherapy
Recipient
Sloan-Kettering Inst Can Research
Award Amount
$52,800.00
Ceiling
$52,800.00
Awarded
September 16, 2025
Identifier
11194517
Award for a research project studying immune features related to genetic variants and immunotherapy response in lung cancer, funded by the National Cancer Institute.
Description
The project focuses on immune features linked to genetic variants and response to immunotherapy in lung cancer. It involves immune profiling, genetic analysis, and biomarker characterization to improve diagnostic testing and therapeutic targeting in lung cancer. The project duration is from September 1, 2025, to August 31, 2026.